Murine immunodeficiency virus-induced peripheral neuropathy and the associated cytokine responses

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3724-3733

  Cao, Ling ^a   Butler, M Brady ^a   Tan, Leonard ^a   Draleau, Kyle S ^a   Koh, Woon Yuen ^b  

^a UNIVERSITY OF NEW ENGLAND   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; ZIDOVUDINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL ROOT; HINDLIMB; HUMAN IMMUNODEFICIENCY VIRUS; LUMBAR SPINAL CORD; MALE; MOUSE; MURINE IMMUNODEFICIENCY VIRUS; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; SKIN; SPLEEN; VIRUS LOAD;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROVIRIDAE INFECTIONS; RNA, MESSENGER;

EID: 84866538149     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201313     Document Type: Article

References (53)

1. Cornblath, D. R., and A. Hoke. 2006. Recent advances in HIV neuropathy. Curr. Opin. Neurol. 19: 446-450.
2. Pardo, C. A., J. C. McArthur, and J.W. Griffin. 2001. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J. Peripher. Nerv. Syst. 6: 21-27.
3. So, Y. T., D. M. Holtzman, D. I. Abrams, and R. K. Olney. 1988. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch. Neurol. 45: 945-948.
4. Pettersen, J. A., G. Jones, C. Worthington, H. B. Krentz, O. T. Keppler, A. Hoke, M. J. Gill, and C. Power. 2006. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitormediated neurotoxicity. Ann. Neurol. 59: 816-824.
5. Jensen, T. S., R. Baron, M. Haanpää, E. Kalso, J. D. Loeser, A. S. Rice, and R. D. Treede. 2011. A new definition of neuropathic pain. Pain 152: 2204-2205.
6. Polydefkis, M., C. T. Yiannoutsos, B. A. Cohen, H. Hollander, G. Schifitto, D. B. Clifford, D. M. Simpson, D. Katzenstein, S. Shriver, P. Hauer, et al. 2002. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58: 115-119.
7. Latarjet, R., and J. F. Duplan. 1962. Experiment and discussion on leukaemo-genesis by cell-free extracts of radiation-induced leukaemia in mice. Int. J. Radiat. Biol. 5: 339-344.
8. Chattopadhyay, S. K., H. C. Morse, III, M. Makino, S. K. Ruscetti, and J. W. Hartley. 1989. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 86: 3862-3866.
9. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J. 5: 2398-2405.
10. Sei, Y., Y. Kustova, Y. Li, H. C. Morse, III, P. Skolnick, and A. S. Basile. 1998. The encephalopathy associated with murine acquired immunodeficiency syndrome. Ann. N. Y. Acad. Sci. 840: 822-834.
11. Sei, Y., P. K. Arora, P. Skolnick, and I. A. Paul. 1992. Spatial learning impairment in a murine model of AIDS. FASEB J. 6: 3008-3013.
12. Kustova, Y., M. G. Espey, E. G. Sung, D. Morse, Y. Sei, and A. S. Basile. 1998. Evidence of neuronal degeneration in C57B1/6 mice infected with the LP-BM5 leukemia retrovirus mixture. Mol. Chem. Neuropathol. 35: 39-59.
13. Chen, G. J., and R. R. Watson. 1991. Modulation of tumor necrosis factor and gamma interferon production by cocaine and morphine in aging mice infected with LP-BM5, a murine retrovirus. J. Leukoc. Biol. 50: 349-355.
14. Cheung, S. C., S. K. Chattopadhyay, H. C. Morse, III, and P. M. Pitha. 1991. Expression of defective virus and cytokine genes in murine AIDS. J. Virol. 65: 823-828.
15. Morawetz, R. A., N. A. Giese, L. Gabriele, P. Rothman, I. Horak, K. Ozato, and H. C. Morse, III. 1998. Relationship of cytokines and cytokine signaling to immunodeficiency disorders in the mouse. Braz. J. Med. Biol. Res. 31: 61-67.
16. Iida, R., K. Saito, K. Yamada, A. S. Basile, K. Sekikawa, M. Takemura, H. Fujii, H. Wada, M. Seishima, and T. Nabeshima. 2000. Suppression of neurocognitive damage in LP-BM5-infected mice with a targeted deletion of the TNF-alpha gene. FASEB J. 14: 1023-1031.
17. Koustova, E., Y. Sei, T. McCarty, M. G. Espey, R. Ming, H. C. Morse, III, and A. S. Basile. 2000. Accelerated development of neurochemical and behavioral deficits in LP-BM5 infected mice with targeted deletions of the IFN-gamma gene. J. Neuroimmunol. 108: 112-121.
18. Eiseman, J. L., R. A. Yetter, T. N. Fredrickson, S. G. Shapiro, C. MacAuley, and J. A. Bilello. 1991. Effect of 3'azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS. Antiviral Res. 16: 307-326.
19. Magnani, M., A. Casabianca, A. Fraternale, G. Brandi, L. Chiarantini, U. Benatti, S. Scarfì, E. Millo, and A. De Flora. 1998. Inhibition of murine AIDS by a new azidothymidine homodinucleotide. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17: 189-195.
20. Dias, A. S., M. J. Bester, R. F. Britz, and Z. Apostolides. 2006. Animal models used for the evaluation of antiretroviral therapies. Curr. HIV Res. 4: 431-446.
21. Arenas-Pinto, A., K. Bhaskaran, D. Dunn, and I. V. Weller. 2008. The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antivir. Ther. (Lond.) 13: 289-295.
22. Keswani, S. C., B. Chander, C. Hasan, J. W. Griffin, J. C. McArthur, and A. Hoke. 2003. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann. Neurol. 53: 57-64.
23. Simpson, D. M., and M. Tagliati. 1995. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9: 153-161.
24. Klinken, S. P., T. N. Fredrickson, J. W. Hartley, R. A. Yetter, and H. C. Morse, III. 1988. Evolution of B cell lineage lymphomas in mice with a retrovirusinduced immunodeficiency syndrome, MAIDS. J. Immunol. 140: 1123-1131.
25. Green, K. A., R. J. Noelle, B. G. Durell, and W. R. Green. 2001. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency. J. Virol. 75: 3581-3589.
26. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970. Plaque assay techniques for murine leukemia viruses. Virology 42: 1136-1139.
27. Li, W., and W. R. Green. 2006. The role of CD4 T cells in the pathogenesis of murine AIDS. J. Virol. 80: 5777-5789.
28. Cao, L., and J. A. DeLeo. 2008. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur. J. Immunol. 38: 448-458.
29. Chaplan, S. R., F. W. Bach, J. W. Pogrel, J. M. Chung, and T. L. Yaksh. 1994. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53: 55-63.
30. Cook, W. J., K. A. Green, J. J. Obar, and W. R. Green. 2003. Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR. J. Virol. Methods 108: 49-58.
31. Giese, N. A., T. Giese, and H. C. Morse, III. 1994. Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cells. J. Virol. 68: 5819-5824.
32. Keswani, S. C., C. Jack, C. Zhou, and A. Höke. 2006. Establishment of a rodent model of HIV-associated sensory neuropathy. J. Neurosci. 26: 10299-10304.
33. Cao, L., C. D. Palmer, J. T. Malon, and J. A. De Leo. 2009. Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain. Eur. J. Immunol. 39: 3562-3569.
34. Christophi, G. P., C. A. Hudson, M. Panos, R. C. Gruber, and P. T. Massa. 2009. Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease. J. Virol. 83: 522-539.
35. Cheng, C., G. F. Guo, J. A. Martinez, V. Singh, and D. W. Zochodne. 2010. Dynamic plasticity of axons within a cutaneous milieu. J. Neurosci. 30: 14735-14744.
36. Fantini, F., and O. Johansson. 1992. Expression of growth-associated protein 43 and nerve growth factor receptor in human skin: a comparative immunohistochemical investigation. J. Invest. Dermatol. 99: 734-742.
37. Fraternale, A., A. Casabianca, L. Rossi, L. Chiarantini, G. Brandi, G. Aluigi, G. F. Schiavano, and M. Magnani. 1996. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 59-triphosphate. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12: 164-173.
38. Burdo, T. H., K. Orzechowski, H. L. Knight, A. D. Miller, and K. Williams. 2012. Dorsal root ganglia damage in SIV-infected rhesus macaques: an animal model of HIV-induced sensory neuropathy. Am. J. Pathol. 180: 1362-1369.
39. Kennedy, J. M., A. Hoke, Y. Zhu, J. B. Johnston, G. van Marle, C. Silva, D. W. Zochodne, and C. Power. 2004. Peripheral neuropathy in lentivirus infection: evidence of inflammation and axonal injury. AIDS 18: 1241-1250.
40. Laast, V. A., C. A. Pardo, P. M. Tarwater, S. E. Queen, T. A. Reinhart, M. Ghosh, R. J. Adams, M. C. Zink, and J. L. Mankowski. 2007. Pathogenesis of simian immunodeficiency virus-induced alterations in macaque trigeminal ganglia. J. Neuropathol. Exp. Neurol. 66: 26-34.
41. Zhu, Y., J. M. Antony, J. A. Martinez, D. M. Glerum, V. Brussee, A. Hoke, D. Zochodne, and C. Power. 2007. Didanosine causes sensory neuropathy in an HIV/AIDS animal model: impaired mitochondrial and neurotrophic factor gene expression. Brain 130: 2011-2023.
42. Wallace, V. C., J. Blackbeard, T. Pheby, A. R. Segerdahl, M. Davies, F. Hasnie, S. Hall, S. B. McMahon, and A. S. Rice. 2007. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 133: 47-63.
43. Herzberg, U., and J. Sagen. 2001. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J. Neuroimmunol. 116: 29-39.
44. Milligan, E. D., K. K. Mehmert, J. L. Hinde, L. O. Harvey, D. Martin, K. J. Tracey, S. F. Maier, and L. R. Watkins. 2000. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861: 105-116.
45. Minami, T., S. Matsumura, T. Mabuchi, T. Kobayashi, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and S. Ito. 2003. Functional evidence for interaction between prostaglandin EP3 and kappa-opioid receptor pathways in tactile pain induced by human immunodeficiency virus type-1 (HIV-1) glycoprotein gp120. Neuropharmacology 45: 96-105.
46. Cherry, C. L., A. Rosenow, J. S. Affandi, J. C. McArthur, S. L. Wesselingh, and P. Price. 2008. Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk. AIDS Res. Hum. Retroviruses 24: 117-123.
47. Chew, C. S., C. L. Cherry, D. Imran, E. Yunihastuti, A. Kamarulzaman, S. Varna, R. Ismail, M. Phipps, Z. Aghafar, I. Gut, and P. Price. 2011. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients. Tissue Antigens 77: 126-130.
48. Keswani, S. C., M. Polley, C. A. Pardo, J. W. Griffin, J. C. McArthur, and A. Hoke. 2003. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann. Neurol. 54: 287-296.
49. Wesselingh, S. L., J. Glass, J. C. McArthur, J. W. Griffin, and D. E. Griffin. 1994. Cytokine dysregulation in HIV-associated neurological disease. Adv. Neuroimmunol. 4: 199-206.
50. Yoshioka, M., W. G. Bradley, P. Shapshak, I. Nagano, R. V. Stewart, K. Q. Xin, A. K. Srivastava, and S. Nakamura. 1995. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv. Neuroimmunol. 5: 335-358.
51. Zheng, W., H. Ouyang, X. Zheng, S. Liu, M. Mata, D. J. Fink, and S. Hao. 2011. Glial TNFa in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol. Pain 7: 40.
52. Schifitto, G., M. P. McDermott, J. C. McArthur, K. Marder, N. Sacktor, L. Epstein, and K. Kieburtz; Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. 2002. Incidence of and risk factors for HIVassociated distal sensory polyneuropathy. Neurology 58: 1764-1768.
53. Simpson, D. M. 2002. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J. Neurovirol. 8 (Suppl 2): 33-41.